Review of Phytotherapy for Anxiety Disorders
Introduction to the Study
Researchers have recently undertaken a comprehensive review to evaluate the effectiveness of phytotherapy in treating anxiety disorders. This initiative aims to discover plant-based medications that may present fewer side effects and risks compared to conventional treatments. Anxiety disorders are prevalent chronic conditions, recognized as the most commonly diagnosed mental health issues in Canada.
Understanding Anxiety and GABA
A key neurotransmitter linked to anxiety is gamma-aminobutyric acid (GABA). While current pharmacotherapeutic options targeting GABA pathways in the brain are effective, they are often associated with addiction and various adverse effects. As a result, there is growing interest in exploring alternative plant-based treatments that could alleviate anxiety with reduced negative side effects. Phytomedicines, which consist of whole plants or plant-derived compounds, hold potential in preventing or treating disease symptoms.
Research Methodology
The research team from the Department of Psychiatry at the University of Melbourne in Australia reviewed preclinical and clinical studies involving various phytotherapies that act on GABA pathways. Their systematic review aimed to gather evidence on the efficacy of these treatments in vitro, in animal studies, and in human subjects. The findings were published in the journal Phytotherapy Research.
Kava: The Most Effective Phytotherapy
Among the evaluated treatments, Kava, a plant native to the South Pacific, demonstrated the highest efficacy for treating anxiety disorders. Evidence from both in vitro and animal studies indicated its significant activity in the GABA pathways, outperforming placebo in clinical trials involving humans.
Other Phytotherapies Examined
The review also included other plant-based treatments such as chamomile, passionflower, valerian, Indian ginseng, and pennywort. Each of these phytotherapies exhibited GABA-ergic activity in laboratory settings and showed reductions in stress levels and anxiety ratings in both animal and human studies. However, the precise mechanisms and sites of GABA-ergic activity in the brain for these treatments remain largely unexplored, necessitating further investigation into the specific constituents of these extracts.
Additional Phytotherapy Classes
Other classes of phytotherapy that appeared to influence the GABA pathway, including maidenhair, hops, lemon balm, and skullcap, were also reviewed. Unfortunately, there is insufficient evidence to support their efficacy in treating anxiety disorders among human patients. For these and numerous other phytomedicines excluded from the review, additional research is essential to examine their anxiety-reducing effects on the human brain. More in vitro studies focusing on the mechanisms that modulate GABA pathways could facilitate future human studies aiming to identify new and safe phytotherapies for anxiety treatment.
Need for Rigorous Studies
Anxiety disorders affect approximately 3% of the Canadian population each year, highlighting the pressing need for effective and safe treatment options. Although the current review indicates promising results from various ancient medicines, it also underscores the necessity for more rigorous human studies to confirm the efficacy and safety of phytotherapy. This systematic review is the first to compile evidence from in vitro, animal, and human studies regarding the positive effects of these natural treatments on anxiety disorders.
Conclusion
The findings from this research may pave the way for new avenues in the treatment of anxiety disorders through phytotherapy, emphasizing the importance of further exploration in this field.
References
(1) Savage K, Firth J, Stough C et al. GABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence. Phytotherapy Research. 2017
(2) Statistica Canada. Section B Anxiety Disorders. Part 4 General Anxiety Disorder. http://www.statcan.gc.ca/pub/82-619-m/2012004/sections/sectionb-eng.htm#a4